Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Puma Biotechnology
PBYI
$404M
| $3.29M | ﹤0.01% |
161,711
-1,833
| -1% | -$55K |
|
2127
Tootsie Roll Industries
TR
$2.93B
| $3.29M | ﹤0.01% |
124,758
-7,562
| -6% | -$193K |
|
|
REN
2128
DELISTED
Resolute Energy Corporaton
REN
| $3.28M | ﹤0.01% |
113,226
-875
| -0.8% | -$27.6K |
|
2129
Lantheus
LNTH
$6.49B
| $3.26M | ﹤0.01% |
208,238
-41
| -0% | -$628 |
|
|
TAST
2130
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $3.26M | ﹤0.01% |
330,982
+77,435
| +31% | +$925K |
|
2131
Gates Industrial Corporation Ltd.
GTES
$7.08B
| $3.24M | ﹤0.01% |
244,796
+4,516
| +2% | +$67.8K |
|
|
EIGI
2132
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $3.23M | ﹤0.01% |
485,270
-285,031
| -37% | -$2.36M |
|
2133
Mercantile Bank Corp
MBWM
$1.04B
| $3.23M | ﹤0.01% |
114,183
+2,166
| +2% | +$67.2K |
|
2134
Republic Bancorp
RBCAA
$1.95B
| $3.21M | ﹤0.01% |
83,028
+4,063
| +5% | +$175K |
|
2135
Angi Inc
ANGI
$229M
| $3.21M | ﹤0.01% |
19,996
+1,772
| +10% | +$321K |
|
2136
German American Bancorp
GABC
$1.91B
| $3.19M | ﹤0.01% |
114,870
-90
| -0.1% | -$2.8K |
|
|
HSKA
2137
DELISTED
Heska Corp
HSKA
| $3.19M | ﹤0.01% |
37,019
-488
| -1% | -$48K |
|
|
FTSI
2138
DELISTED
FTS International, Inc. Common Stock
FTSI
| $3.18M | ﹤0.01% |
22,381
+1,918
| +9% | +$404K |
|
2139
Axcelis
ACLS
$4.01B
| $3.18M | ﹤0.01% |
178,748
+2,322
| +1% | +$41.3K |
|
|
EGRX
2140
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.16M | ﹤0.01% |
78,432
-5,237
| -6% | -$270K |
|
2141
FB Financial Corp
FBK
$3.02B
| $3.16M | ﹤0.01% |
90,187
-288
| -0.3% | -$10.6K |
|
2142
Horizon Bancorp
HBNC
$1.04B
| $3.15M | ﹤0.01% |
199,802
-376
| -0.2% | -$6.44K |
|
2143
Icon
ICLR
$12.6B
| $3.15M | ﹤0.01% |
24,395
-1,476
| -6% | -$204K |
|
2144
StoneX
SNEX
$9.26B
| $3.14M | ﹤0.01% |
434,975
+6,288
| +1% | +$53.3K |
|
|
APTS
2145
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $3.14M | ﹤0.01% |
223,535
-2,449
| -1% | -$38.3K |
|
|
USCR
2146
DELISTED
U S Concrete, Inc.
USCR
| $3.13M | ﹤0.01% |
88,745
-1,024
| -1% | -$37.1K |
|
|
JAG
2147
DELISTED
Jagged Peak Energy Inc.
JAG
| $3.13M | ﹤0.01% |
342,904
-2,374
| -0.7% | -$28.4K |
|
2148
CorVel
CRVL
$3.06B
| $3.12M | ﹤0.01% |
151,839
-1,017
| -0.7% | -$20.7K |
|
2149
MacroGenics
MGNX
$235M
| $3.11M | ﹤0.01% |
244,672
-2,213
| -0.9% | -$37.1K |
|
|
NVEE
2150
DELISTED
NV5 Global
NVEE
| $3.1M | ﹤0.01% |
204,840
-352
| -0.2% | -$6.53K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.